Natera, Inc. (NASDAQ:NASDAQ:NTRA) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive.
Zymeworks Inc. (NYSE:NYSE:ZYME) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair.
/PRNewswire/ GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative.
GT Biopharma Provides Second Quarter 2021 Business Update biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.